Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Conversion of 3,294,900 CTY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | CITY THERAPEUTICS, INC. (CTY) | Conversion | 3,294,900 | n/a |
| Jul 6, 2026 | Boundless Bio, Inc. (BOLD) | Exercise/Conversion | 16,000 | $16.5K |
| Jun 24, 2026 | Kardigan, Inc. (KARD) | Purchase | 1,250,000 | $20.00M |
| Jun 22, 2026 | Kardigan, Inc. (KARD) | Conversion | 13,792,035 | n/a |
| Jun 8, 2026 | Prime Medicine, Inc. (PRME) | Grant/Award | 75,000 | n/a |
| Jun 5, 2026 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 90,000 | n/a |
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Conversion | 2,513,686 | n/a |
| Mar 9, 2026 | Lyell Immunopharma, Inc. (LYEL) | Purchase | 488,090 | $12.50M |
| Oct 29, 2025 | Neumora Therapeutics, Inc. (NMRA) | Purchase | 1,915,700 | $5.00M |
| Aug 6, 2025 | Prime Medicine, Inc. (PRME) | Disposition to Issuer | 39,062 | n/a |